K
48
3
KLAC
56
11
MTCH
71
9
MOS
38
2
REGN
44
2
EQIX
57
-2
MDLZ
30
2
FFIV
63
2
NTRS
39
2
ISRG
66
2
PRU
45
6
NEE
42
3
PFG
30
3
NUE
39
2
XRX
59
11
STT
59
11
GM
57
2
EQT
50
3
CHRW
51
-2
UNH
44
2
K
48
3
KLAC
56
11
MTCH
71
9
MOS
38
2
REGN
44
2
EQIX
57
-2
MDLZ
30
2
FFIV
63
2
NTRS
39
2
ISRG
66
2
PRU
45
6
NEE
42
3
PFG
30
3
NUE
39
2
XRX
59
11
STT
59
11
GM
57
2
EQT
50
3
CHRW
51
-2
UNH
44
2
Financhill
Back

Outlook Therapeutics Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
16

OTLK
Outlook Therapeutics

Last Price:
$1.48
Seasonality Move:
25.75%

7 Day Trial

ALL ACCESS PASS

$ 7

Elon Musk Predicts MAJOR Crisis in Trump's First Year

See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.

Outlook Therapeutics Stock Forecast

  • Is Outlook Therapeutics Stock Undervalued?
    The current Outlook Therapeutics [OTLK] share price is $1.42. The Score for OTLK is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
  • OTLK is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Outlook Therapeutics Stock Go Up Next Year?

Data Unavailable

Outlook Therapeutics Stock Rating

Data Unavailable

Outlook Therapeutics Stock Price History

Is OTLK stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OTLK is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
outlooktherapeutics.com

52-Week Data

52-Week High:
12.85
52-Week Low:
0.87

Prediction Charts

Market Cap:
33.6M
Price in USD:
1.42
Volume:
787.2K
Beta:
0.21

Technical Analysis

SMA50:
4.16
SMA100:
5.38
SMA200:
6.70
52-Wk Change:
-83.22%

Stock Predictions

  • Is Outlook Therapeutics stock public?
    Yes, Outlook Therapeutics is a publicly traded company.
  • What is the Outlook Therapeutics stock quote today?
    The Outlook Therapeutics stock price is 1.42 USD today.
  • How to buy Outlook Therapeutics stock online?
    You can buy Outlook Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-5 1.68 1.47 1.68 1.45
Dec-6 1.56 1.52 1.58 1.47
Dec-9 1.53 1.70 1.88 1.53
Dec-10 1.74 1.61 1.85 1.60
Dec-11 1.60 1.57 1.62 1.50
Dec-12 1.58 1.54 1.65 1.52
Dec-13 1.53 1.48 1.53 1.43
Dec-16 1.48 1.43 1.50 1.41
Dec-17 1.40 1.44 1.46 1.35
Dec-18 1.40 1.40 1.59 1.36
Dec-19 1.40 1.39 1.50 1.35
Dec-20 1.38 1.44 1.47 1.34
Dec-23 1.45 1.42 1.47 1.26
Dec-24 1.42 1.47 1.53 1.36

Outlook Therapeutics Earnings

Data Unavailable

Outlook Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.39 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.74 per share, and an increase next year of $1.39 per share.

* Outlook Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.